BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12815710)

  • 21. Measurement of cellular beta-site of APP cleaving enzyme 1 activity and its modulation in neuronal assay systems.
    Volbracht C; Penzkofer S; Mansson D; Christensen KV; Fog K; Schildknecht S; Leist M; Nielsen J
    Anal Biochem; 2009 Apr; 387(2):208-20. PubMed ID: 19454261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of the APP proximal promoter and 5'-untranslated regions: identification of cell type-specific domains and implications in APP gene expression and Alzheimer's disease.
    Lahiri DK; Ge YW; Maloney B
    FASEB J; 2005 Apr; 19(6):653-5. PubMed ID: 15703276
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sp3 repression of polymorphic human NRH:quinone oxidoreductase 2 gene promoter.
    Wang W; Jaiswal AK
    Free Radic Biol Med; 2004 Oct; 37(8):1231-43. PubMed ID: 15451063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
    Zhou D; Masri S; Ye JJ; Chen S
    Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of the promoter of human transcription factor Sp3 and evidence of the role of factors Sp1 and Sp3 in the expression of Sp3 protein.
    Lou Z; Maher VM; McCormick JJ
    Gene; 2005 May; 351():51-9. PubMed ID: 15857802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of the infection-responsive bovine lactoferrin promoter.
    Zheng J; Ather JL; Sonstegard TS; Kerr DE
    Gene; 2005 Jun; 353(1):107-17. PubMed ID: 15935571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of KLF5 involves the Sp1 transcription factor in human epithelial cells.
    Chen C; Zhou Y; Zhou Z; Sun X; Otto KB; Uht RM; Dong JT
    Gene; 2004 Apr; 330():133-42. PubMed ID: 15087132
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The proximal promoter of the human cathepsin G gene conferring myeloid-specific expression includes C/EBP, c-myb and PU.1 binding sites.
    Lennartsson A; Garwicz D; Lindmark A; Gullberg U
    Gene; 2005 Aug; 356():193-202. PubMed ID: 16019164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional domains of the BACE1 and BACE2 promoters and mechanisms of transcriptional suppression of the BACE2 promoter in normal neuronal cells.
    Lahiri DK; Maloney B; Ge YW
    J Mol Neurosci; 2006; 29(1):65-80. PubMed ID: 16757811
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sp1 site is crucial for the mouse claudin-19 gene expression in the kidney cells.
    Luk JM; Tong MK; Mok BW; Tam PC; Yeung WS; Lee KF
    FEBS Lett; 2004 Dec; 578(3):251-6. PubMed ID: 15589828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. S-Adenosylhomocysteine increases beta-amyloid formation in BV-2 microglial cells by increased expressions of beta-amyloid precursor protein and presenilin 1 and by hypomethylation of these gene promoters.
    Lin HC; Hsieh HM; Chen YH; Hu ML
    Neurotoxicology; 2009 Jul; 30(4):622-7. PubMed ID: 19635394
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of human UDP-glucose dehydrogenase gene promoter: identification of an Sp1 binding site crucial for the expression of the large transcript.
    Vatsyayan J; Peng HL; Chang HY
    J Biochem; 2005 Jun; 137(6):703-9. PubMed ID: 16002992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of BACE1 stimulates spontaneous basal secretion in PC12 cells.
    Lee HW; Seo HS; Ha I; Chung SH
    Neurosci Lett; 2007 Jun; 421(2):178-83. PubMed ID: 17566645
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sp1 and AP2 enhance promoter activity of the mouse GM3-synthase gene.
    Xia T; Zeng G; Gao L; Yu RK
    Gene; 2005 May; 351():109-18. PubMed ID: 15890474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular analysis of the promoter region of the gene encoding the beta-amyloid precursor protein.
    Lahiri DK
    Indian J Biochem Biophys; 1995 Dec; 32(6):329-35. PubMed ID: 8714200
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of the seabass pancreatic alpha-amylase gene and promoter.
    Ma P; Liu Y; Reddy KP; Chan WK; Lam TJ
    Gen Comp Endocrinol; 2004 May; 137(1):78-88. PubMed ID: 15094338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcriptional regulation of BACE1, the beta-amyloid precursor protein beta-secretase, by Sp1.
    Christensen MA; Zhou W; Qing H; Lehman A; Philipsen S; Song W
    Mol Cell Biol; 2004 Jan; 24(2):865-74. PubMed ID: 14701757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Common regulatory elements in the polycystic kidney disease 1 and 2 promoter regions.
    Lantinga-van Leeuwen IS; Leonhard WN; Dauwerse H; Baelde HJ; van Oost BA; Breuning MH; Peters DJ
    Eur J Hum Genet; 2005 May; 13(5):649-59. PubMed ID: 15770226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of the Wnt/β-catenin pathway represses the transcription of the β-amyloid precursor protein cleaving enzyme (BACE1) via binding of T-cell factor-4 to BACE1 promoter.
    Parr C; Mirzaei N; Christian M; Sastre M
    FASEB J; 2015 Feb; 29(2):623-35. PubMed ID: 25384422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular basis of neuroendocrine cell type-specific expression of the chromogranin B gene: Crucial role of the transcription factors CREB, AP-2, Egr-1 and Sp1.
    Mahapatra NR; Mahata M; Ghosh S; Gayen JR; O'Connor DT; Mahata SK
    J Neurochem; 2006 Oct; 99(1):119-33. PubMed ID: 16987240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.